(Q41734057)

8 October 2017

1 reference

title

An economic analysis of kidney transplantation (English)

1 reference

8 October 2017

Evans RW

1

1 reference

PubMed ID

9531941

8 October 2017

Kitzmann DJ

series ordinal

2

1 reference

8 October 2017

1 February 1998

1 reference

Surgical Clinics of North America

8 October 2017

1 reference

8 October 2017

78

1 reference

8 October 2017

1

1 reference

8 October 2017

149-174

1 reference

The crisis in clinical cancer research. Third-party insurance and investigational therapy.

8 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970640-X

7 January 2021

Transplant failure does not compromise quality of life in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970640-X

7 January 2021

The HMO backlash--righteous or reactionary?

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970640-X

7 January 2021

The social and economic cost of end-stage renal disease. A patient's perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970640-X

7 January 2021

Evidence based medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970640-X

7 January 2021

Cost-effectiveness analysis of transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970640-X

7 January 2021

Coverage and reimbursement for heart transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970640-X

7 January 2021

Public and private insurer designation of transplantation programs

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970640-X

7 January 2021

Liver transplantation in a managed care environment

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970640-X

7 January 2021

Contracting for services: liver transplantation in the era of mismanaged care

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970640-X

7 January 2021

The quality of life of patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970640-X

7 January 2021

Cost-effectiveness analysis of end-stage renal disease treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970640-X

7 January 2021

Evidence based medicine: Socratic dissent

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970640-X

7 January 2021

The American health care system. Managed care

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970640-X

7 January 2021

Physicians and the growth of managed care

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970640-X

7 January 2021

The struggle between managed care and fee-for-service practice

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970640-X

7 January 2021

The new dominance of managed care: insurance trends in the 1990s

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970640-X

7 January 2021

Xenotransplants. IOM backs cautious experimentation

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970640-X

7 January 2021

Cost-Effectiveness Studies of Renal Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970640-X

7 January 2021

Is managed care here to stay?

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970640-X

7 January 2021

Evidence-based medicine: an incomplete method for informing treatment choices

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970640-X

7 January 2021

Defining experimental therapy--a third-party payer's dilemma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970640-X

7 January 2021

Cost-effective care of end-stage renal disease: a billion dollar question

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970640-X

7 January 2021

Cadaveric renal transplant failure: the short-term sequelae

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970640-X

7 January 2021

Evidence based medicine: what it is and what it isn't

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970640-X

7 January 2021

Cost-effectiveness analysis of organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970640-X

7 January 2021

Predicting Treatment Costs and Life Expectancy for End-Stage Renal Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970640-X

7 January 2021

Insurance coverage for experimental technologies

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970640-X

7 January 2021

Transplantation and home hemodialysis: their cost-effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970640-X

7 January 2021

Decision-support systems in health care. Factors influencing the development and transfer of technology.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970640-X

7 January 2021

Socioeconomic aspects of heart transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970640-X

7 January 2021

The functional status of ESRD patients as measured by the Sickness Impact Profile.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970640-X

7 January 2021

10.1016/S0039-6109(05)70640-X

Identifiers

DOI

1 reference

8 October 2017

1 reference

PubMed ID

9531941